Newsfeeds Archive - Spark Newswire

2 minute read

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment

June 5, 3:26 PM

FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.

ATAI

3 minute read

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More

By Lara Goldstein

April 17, 8:42 AM

DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings The Drug Enforcement Administration (DEA)…

AGNPF

4 minute read

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence

By Lara Goldstein

March 29, 12:43 PM

Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have…

ATAI

4 minute read

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More

By Lara Goldstein

February 15, 9:36 AM

Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last Months A new study…

ATAI

4 minute read

Psyched: Suggestibility And Psychedelics’ Effects, EU’s $7M Research Fund, Australia’s Treatment Delivery, BZ Podcast And More

By Lara Goldstein

January 27, 11:00 AM

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.

ATAI

3 minute read

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More

By Lara Goldstein

January 12, 5:55 PM

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

ATAI

3 minute read

Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai’s $50M And More

By Lara Goldstein

January 7, 1:36 PM

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury

ATAI

5 minute read

Psyched: Biden Approves Psychedelics Trials, RFK, Australia’s First Legal Dedicated Clinic & More

By Lara Goldstein

December 27, 11:09 AM

President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.

ATAI